Genmab A GNMSF
NASDAQ GNMSF
$335.00 +15.00 (+4.69%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genmab A/S (GNMSF) Capital Expenditures (2024 - 2025)

Genmab A's (GNMSF) quarterly Capital Expenditures came in at $22.0 million in Q2 2025, up 175.0% YoY from $8.0 million in Q2 2024, and up 175.0% on a QoQ basis from $8.0 million in Q2 2024.

Genmab A/S (GNMSF) Capital Expenditures (2024 - 2025) Analysis & Trends

Genmab A (GNMSF) has 2 years of Capital Expenditures data on file, last reported at $22.0 million in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2025 22.00 Mn
Jun 30, 2025 22.00 Mn
Jun 30, 2024 8.00 Mn
Jun 30, 2024 8.00 Mn